Navigation Links
European Centre for Modern Drug Discovery Established in Hamburg
Date:9/3/2007

plement their own drug research.

ScreeningPort is planned to be at the heart of an international network. Although it is still at an early stage, a number of European research institutes have already been tied in. Among others, the Swiss Federal Institute of Technology (ETH Zurich) and the Vienna-based Institute of Molecular Biotechnology of the Austrian Academy of Sciences have signed letters of intent.

The ScreeningPort project was initiated by Evotec AG, a leading drug discovery and development company, bringing in its extensive expertise. It was implemented by Norgenta GmbH, the north German life science agency that promotes the structural development of life sciences in the federal states of Hamburg and Schleswig-Holstein.

Other partners are also raring to go, such as c.a.r.u.s. IT AG, a company specialised in high-performance data management solutions for life sciences.

Statements:

Thomas Rachel, member of the German federal parliament and parliamentary secretary of state at the German Federal Ministry of Education and Research:

"ScreeningPort is an important element to close the gap between basic research and the commercial development of new therapeutics. Therefore the Federal Ministry of Education and Research has decided to financially support, as part of its Pharmaceuticals Initiative for Germany campaign, the establishment of the ScreeningPort and initial pilot projects in screening. Total funding of more than EUR 800 million will be provided by 2011 under this initiative which is aimed at accelerating the development of innovative therapeutics for patients."

Senator Gunnar Uldall, Head of the State Ministry of Economic and Labour Affairs, City of Hamburg:

"By funding and implementing this project, we continue and further complement our successful cluster policy for the life sciences in northern Germany. The new ScreeningPort provides Hamburg with the opportunity to become a leading European centre of moder
'/>"/>

SOURCE Evotec AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Info security group announces first Eastern European chapter
3. EMD Biosciences partners with European biotech company
4. Third Wave lands European distribution deal, reports high earnings
5. The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists
6. A (modern) Tale of Two Cities: Milwaukee and Madison inch together
7. Building the modern public-purpose university should be UW Systems goal
8. Modernizing the tax code can make Wisconsin tech businesses more competitive
9. SEESNP DISCOVERY
10. siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005)
11. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  Having the right people ... vital to accelerating business growth and achieving clinical and ... Association (AHA) Leadership Summit, July 20-22, 2014, in ... of hospital executives and healthcare experts discussing how partnerships ... Carrocino , President & Chief Executive Officer of Cape ...
(Date:7/23/2014)... Israel , July 23, 2014 ... a portfolio company of Trendlines Agtech , ... of Israel,s leading agricultural ... , Valentis,s technology combines nanocrystalline cellulose ... pulp waste, with additional nanoparticles to produce highly ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)...  Sofinnova Ventures, a Menlo Park ... Sofinnova Venture Partners IX, L.P. at the hard cap ... fund target of $425 million. Sofinnova focuses ... with recent funds, SVP IX will provide capital primarily ... with select investments in earlier stage opportunities. Investments will ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2
... AVIV, Israel, September 23 InspireMD, Ltd.,announced today ... its study of,MGuard(TM) coronary stent in acute myocardial ... Study) is designed to evaluate,the safety and efficacy ... infarction. The first 3 patients were implanted,successfully with ...
... Affitech AS, the Norwegian human,antibody therapeutics company, ... milestone in its research and licensing collaboration ... against an unnamed oncology,target. Affitech has successfully ... that included its proprietary antibody library and ...
... KNDL ), a,leading, global full-service clinical research ... Kendle, PharmD, will,participate in the annual UBS Global ... the Grand Hyatt New York, Park Avenue at ... presentation is,scheduled for Wednesday, September 24 at 9:30 ...
Cached Biology Technology:InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results 2InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results 3Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration 2
(Date:7/23/2014)... A 2C increase in temperature around the world by ... the Intergovernmental Panel on Climate Change (IPCC), may be ... processes involved in the growth of forage plants such ... for livestock grazing in tropical countries such as Brazil., ... researchers in the Department of Biology at the Ribeiro ...
(Date:7/23/2014)... will play an increasingly important role in carbon and ... zones expand, according to research published this week in ... . , University of British Columbia researchers plumbed the ... to chart how microbial community metabolism changes as oxygen ... detailed picture of how SUP05 a bacterial group ...
(Date:7/23/2014)... will publish the International Journal of Fuzzy Systems ... Taiwan Fuzzy Systems Association (TFSA). The cooperation will allow ... area of fuzzy research., The International Journal of ... that deal with the theory, design and application of ... theory systems ranging from hardware to software. Launched in ...
Breaking Biology News(10 mins):An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
... an advance that could help ease the antibiotic drought, ... test that enlists pinhead-sized worms in efforts to discover ... ACS Chemical Biology , a monthly journal. ... that existing methods for identifying germ-fighting drugs involve adding ...
... diplomats and campaigners prepare to attend the COP15 conference ... battle against climate change in one of the most ... increasingly complex territory of climate negotiations is being revealed ... IOP Publishing,s Environmental Research Letters . ...
... A compound initially isolated from a soft coral ( Capnella ... scientists to develop a new set of treatments for neuropathic ... nervous system. Currently this form of pain is very ... or even opioids like morphine) and novel treatments are urgently ...
Cached Biology News:Climate change poker: The barriers which are preventing a global agreement 2Neuropathic pain: The sea provides a new hope of relief 2
... Stabilizer is a bovine protein-free alternative to ... aqueous solution that contains non-toxic chemicals in ... 6.6 - 7.2, and does not contain ... activity of antibodies and other biomolecules that ...
... is designed to stabilize the biomolecules ... storage. There are neither animal ... is a convenient 10 times solution ... superior to other traditional lyophilizing additives ...
... The CERTOMAT IS, a true benchtop incubator-shaker, ... shakers. Having a footprint of 540 x ... a large incubation chamber (370 x 505 x ... orbits, the CERTOMAT IS is ideal for shaking ...
... of the smallest thermal cyclers on the market, ... the 0.5ml (20 samples) or 0.2ml microtube (25 ... heating and cooling rate of 3.6C/sec and 2.0C/sec ... Fast track programming with new quick dial ...
Biology Products: